CircInterventions

How should we guide selection of invasive therapies following an out-of-hospital cardiac arrest? Prospective validation of the MIRACLE2 Score @ncurzen @krishnaraj82 @garryhamilton6 @drR_Simpson @Sam_mc35 @zaidiskandar85 @DrPaulRees ahajrnls.org/4saBexX

📣 Call for Applicants! 📣 @CircOutcomes invites applications for an Associate Editor to join the journal’s new editorial team led by incoming Editor-in-Chief Dr. Dhruv Kazi @kardiologykazi 🗓Apply by April 10 🔗Learn more: ahajournals.org/circpopoutcome… @AHAScience

Angiography-Derived Fractional Flow Reserve During Percutaneous Coronary Intervention. Comparable clinical outcomes compared with pressure-wire assessment through 2-years. LBCT @CRT_meeting #CRT2026 & published simultaneously @wfearonmd @EricSecemskyMD ahajrnls.org/4d84gcQ

Hospital-level Variability in NSTEMI Management: Findings from the NCDR Chest Pain-MI Registry. LBCT presented @CRT_meeting #CRT2026 and published simultaneously @SammourMD @jspertus @PSandesara_MD @SachinGoelMD @safinmc @AlpeshShahMD @TanveerRab @wjn_md ahajrnls.org/3NoSIHO

Low-Dose Rivaroxaban in Patients with Prior Lower Extremity Revascularization. How do the benefits compare to those without prior LER? @DrSoniaAnand1 @me_canonico @marcbonaca ahajrnls.org/46sVToq

Should genotyping guide our treatment strategy? Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in ACS. Observational Evidence from POPULAR-GUIDE PCI @yappelman @NielsvdSangen ahajrnls.org/4sdoC8V

PCI versus Conservative Management before TAVR. No difference in death or MI with PCI in a nationwide study of Swedish Patients @AOskar @AndreasRck2 ahajrnls.org/4tT1rm1

Is tele-proctoring a way of the future for the global dissemination of knowledge for innovative technical procedures? Tele-proctoring for PDA closure ahajrnls.org/4tWNYty

Impact of Restenosis Patterns on the Safety and Efficacy of Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis @rcstoler @ajaykirtane @mobitz @RafaelCav_MD @bigboy1202 @rwyeh ahajrnls.org/4rXzrMa

Should a morphology-guided approach for the treatment of calcified nodules be employed in the cal lab? Enhanced Efficacy of Rotational Atherectomy for Calcified Nodules with Contralateral Calcification @MasashiFujino @yu_kataoka @ynokitaiti @NCVC_official ahajrnls.org/4068mui

Five Year Hemodynamic & Mortality Outcomes Following Valve-in-Valve Transcatheter Aortic Valve Replacement with Balloon Expandable Valves. Lower EF not elevated valve gradient predicts worse outcomes in transcatheter aortic VIV replacement @amrabbasmd ahajrnls.org/3Mie7lB

Three-year Pooled Outcomes of the ALTERRA Trials. Persistent effective treatment for patients with pulmonary regurgitation with the Alterra Adaptive Prestent/SAPIEN 3 THV System @mjgillespie1 @BlankePhilipp @BabaliarosArgos @Shabanasha3011 ahajrnls.org/3Obl88g

How do you manage patients with MI and coronary artery ectasia? Long-term prognosis of acute myocardial infarction caused by diffuse coronary artery ectasia @dryerlikaya @dr.fatihenes ahajrnls.org/4qupCEu

Cardiac Structural Complications Following TAVR. A comprehensive look at the incidence and outcomes in the current TAVR Era @indolficiro @espogiov @luisnombela @MuntaneCarol @victoria_vilata @AsmaratsL @David_delVal_ @MAvvedimento @JorgeNuche ahajrnls.org/4khEtk0

Diabetic patients and PCI. Pre-procedural SGLT2 inhibitors may provide a Reno-protective effect. Insights from the BMC2 Registry @d_sukul @davyhamilton1 ahajrnls.org/46ldM8o

Pulmonary Atresia with VSD. Trans -collateral Retrograde Perforation of the RVOT. A Feasible Catheter-Based Approach @amrabdallah ahajrnls.org/4td6LjM

Timing of extracorporeal membrane oxygenation on outcomes in infarct-related cardiogenic shock. A subanalysis of the ECLS-SHOCK trial @EPTIG @thiele_holger ahajrnls.org/4ahQr8G

How does age affect outcomes for mechanical circulatory support devices in infarction-related cardiogenic shock? @thiele_holger @dirkwestermann ahajrnls.org/4bBNwdn

Patterns of Disease, Pullback Pressure Gradient, and Residual Angina at One-Year. Will PPG define future revascularization strategies? @ColinBerryMD @BernardBruyne @wfearonmd @divaka_perera @GianlucaCampo78 @fer_iver @juliendjdj @DrAllenJ @T_Storozhenko ahajrnls.org/3NPskXE

Hemodynamic performance of self-expanding transcatheter valve superior to balloon-expandable valve for small VIV-TAVR for failed small surgical aortic bioprosthesis. The 3-Year Results of the LYTEN Trial @PPibarot @luisnombela @ENofrerias @victoria_vilata ahajrnls.org/4kg2ibS